Scientists hunt for clues in blood of asthma patients who Don't get better
NCT ID NCT05495932
Summary
This study aimed to understand why some patients with severe asthma do not respond well to the drug mepolizumab. Researchers measured the drug levels in the blood of 50 patients who were already being treated, comparing those who improved with those who did not. The goal was to see if differences in how the body processes the drug explain why it works for some people but not others.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital of Tours
Tours, France, 37044, France
-
university Hospital of Montpellier
Montpellier, France, 34295, France
Conditions
Explore the condition pages connected to this study.